Pink SheetThe field of cell, gene and tissue therapies, now known as regenerative medicine, has seen tremendous and sustained growth in discovery and early-stage development in recent years, but the pipeline of
ScripThe California Institute of Regenerative Medicine (CIRM), which uses $3bn worth of state bond revenue to provide grants and loans for the development of stem cell therapies, approved a $6.2m funding a